The Side of Stimulation: How Auricular Vagus Nerve Targeting Alters the Body’s Drug Response
A randomized, sham-controlled trial investigated the biological effects of manual acupuncture targeting the auricular vagus nerve (aVNS) in women with fibromyalgia. While the primary outcome of pain intensity did not show significant improvement over sham treatment, the study revealed a critical laterality-dependent pharmacodynamic response. Stimulation of the left auricular branch (aVNS-L) produced a distinct immunomodulatory and neuroplastic profile, significantly decreasing pro-inflammatory cytokines like IL-1β and TNF-α while increasing anti-inflammatory cytokines (IL-4, IL-10) and brain-derived neurotrophic factor (BDNF). This suggests the intervention acts as a neuromodulator, influencing key inflammatory and neurotrophic pathways without directly alleviating clinical pain in this cohort.
Why it might matter to you: This research highlights how non-pharmacological neuromodulation can produce measurable, target-specific changes in circulating biomarkers relevant to drug action and disease pathology. For a pharmacologist, it underscores the importance of stimulation site and laterality in clinical trial design for neuromodulatory therapies, which could be considered adjuncts or alternatives to traditional small-molecule drugs. The findings on cytokine and BDNF modulation offer a potential mechanistic bridge for understanding how such interventions might influence pharmacokinetics and pharmacodynamics of co-administered anti-inflammatory or neuroactive agents.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
